Glenmark Pharmaceuticals receives ANDA approval for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity.
In: Contify Life Science News, 2021-03-24
Zeitungsartikel
Zugriff:
Titel: |
Glenmark Pharmaceuticals receives ANDA approval for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity.
|
---|---|
Zeitschrift: | Contify Life Science News, 2021-03-24 |
Veröffentlichung: | 2021 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|